Endogenous interleukin (IL)-17A promotes pristane-induced systemic autoimmunity and lupus nephritis induced by pristane

Clinical and Experimental Immunology

Volumn 176, Issue 3, 2014, Pages 341-350

  Summers, S A ^a,b   Odobasic, D ^a   Khouri, M B ^a   Steinmetz, O M ^c   Yang, Y ^a   Holdsworth, S R ^a,b   Kitching, A R ^a,b  

^a MONASH UNIVERSITY   (Australia)

^b SOUTHERN HEALTH   (Australia)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Glomerulonephritis; Interleukin 17A; Lupus nephritis; Pristane; Systemic lupus erythematosus

Indexed keywords

COMPLEMENT COMPONENT C3; DOUBLE STRANDED DNA ANTIBODY; GAMMA INTERFERON; IMMUNOGLOBULIN G; INTERLEUKIN 17; PRISTANE; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; COMPLEMENT DEPOSITION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GLOMERULONEPHRITIS; HUMORAL IMMUNITY; IMMUNE RESPONSE; INNATE IMMUNITY; KIDNEY INJURY; LUPUS ERYTHEMATOSUS NEPHRITIS; MACROPHAGE; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEINURIA; SPLEEN CELL;

GLOMERULONEPHRITIS; INTERLEUKIN 17A; LUPUS NEPHRITIS; PRISTANE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNITY; COMPLEMENT C3; CYTOKINES; DISEASE MODELS, ANIMAL; GLOMERULONEPHRITIS; HUMANS; IMMUNITY, HUMORAL; IMMUNITY, INNATE; IMMUNOGLOBULIN G; INTERLEUKIN-17; KIDNEY GLOMERULUS; LUPUS NEPHRITIS; MICE; MICE, KNOCKOUT; SPLEEN; TERPENES;

EID: 84899087366     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12287     Document Type: Article

References (45)

1. Ward MM, Pyun E, Studenski S. Mortality risks associated with specific clinical manifestations of systemic lupus erythematosus. Arch Intern Med 1996; 156:1337-1344.
2. Koffler D, Agnello V, Thoburn R, Kunkel HG. Systemic lupus erythematosus: prototype of immune complex nephritis in man. J Exp Med 1971; 134:169s-179.
3. Wofsy D, Seaman WE. Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4. J Exp Med 1985; 161:378-391.
4. Alexopoulos E, Seron D, Hartley RB, Cameron JS. Lupus nephritis: correlation of interstitial cells with glomerular function. Kidney Int 1990; 37:100-109.
5. Anders HJ, Schlondorff DO. Innate immune receptors and autophagy: implications for autoimmune kidney injury. Kidney Int 2010; 78:29-37.
6. Satoh M, Richards HB, Shaheen VM etal. Widespread susceptibility among inbred mouse strains to the induction of lupus autoantibodies by pristane. Clin Exp Immunol 2000; 121:399-405.
7. Richards HB, Satoh M, Jennette JC, Okano T, Kanwar YS, Reeves WH. Disparate T cell requirements of two subsets of lupus-specific autoantibodies in pristane-treated mice. Clin Exp Immunol 1999; 115:547-553.
8. Richards HB, Satoh M, Jennette JC, Croker BP, Yoshida H, Reeves WH. Interferon-gamma is required for lupus nephritis in mice treated with the hydrocarbon oil pristane. Kidney Int 2001; 60:2173-2180.
9. Calvani N, Satoh M, Croker BP, Reeves WH, Richards HB. Nephritogenic autoantibodies but absence of nephritis in Il-12p35-deficient mice with pristane-induced lupus. Kidney Int 2003; 64:897-905.
10. Miossec P, Korn T, Kuchroo VK. Interleukin-17 and type 17 helper T cells. N Engl J Med 2009; 361:888-898.
11. Miossec P, Kolls JK. Targeting IL-17 and TH17 cells in chronic inflammation. Nat Rev Drug Discov 2012; 11:763-776.
12. Wang Y, Ito S, Chino Y etal. Laser microdissection-based analysis of cytokine balance in the kidneys of patients with lupus nephritis. Clin Exp Immunol 2010; 159:1-10.
13. Kyttaris VC, Zhang Z, Kuchroo VK, Oukka M, Tsokos GC. Cutting edge: IL-23 receptor deficiency prevents the development of lupus nephritis in C57BL/6-lpr/lpr mice. J Immunol 2010; 184:4605-4609.
14. Pisitkun P, Ha HL, Wang H etal. Interleukin-17 cytokines are critical in development of fatal lupus glomerulonephritis. Immunity 2012; 37:1104-1115.
15. Summers SA, Hoi A, Steinmetz OM etal. TLR9 and TLR4 are required for the development of autoimmunity and lupus nephritis in pristane nephropathy. J Autoimmun 2010; 35:291-298.
16. Richards HB, Satoh M, Shaw M, Libert C, Poli V, Reeves WH. Interleukin 6 dependence of anti-DNA antibody production: evidence for two pathways of autoantibody formation in pristane-induced lupus. J Exp Med 1998; 188:985-990.
17. Cua DJ, Tato CM. Innate IL-17-producing cells: the sentinels of the immune system. Nature Rev Immunol 2010; 10:479-489.
18. Lin Y, Ritchea S, Logar A etal. Interleukin-17 is required for T helper 1 cell immunity and host resistance to the intracellular pathogen Francisella tularensis. Immunity 2009; 31:799-810.
19. Summers SA, Steinmetz OM, Li M etal. Th1 and Th17 cells induce proliferative glomerulonephritis. J Am Soc Nephrol 2009; 20:2518-2524.
20. Odobasic D, Gan PY, Summers SA etal. Interleukin-17A promotes early but attenuates established disease in crescentic glomerulonephritis in mice. Am J Pathol 2011; 179:1188-1198.
21. Summers SA, van der Veen BS, O'Sullivan KM etal. Intrinsic renal cell and leukocyte-derived TLR4 aggravate experimental anti-MPO glomerulonephritis. Kidney Int 2010; 78:1263-1274.
22. Summers SA, Steinmetz OM, Gan PY etal. Toll-like receptor 2 induces Th17 myeloperoxidase autoimmunity while Toll-like receptor 9 drives Th1 autoimmunity in murine vasculitis. Arthritis Rheum 2011; 63:1124-1135.
23. Lartigue A, Colliou N, Calbo S etal. Critical role of TLR2 and TLR4 in autoantibody production and glomerulonephritis in lpr mutation-induced mouse lupus. J Immunol 2009; 183:6207-6216.
24. Summers SA, Chan J, Gan PY etal. Mast cells mediate acute kidney injury through the production of TNF. J Am Soc Nephrol 2011; 22:2226-2236.
25. Summers SA, Steinmetz OM, Ooi JD etal. Toll-like receptor 9 enhances nephritogenic immunity and glomerular leukocyte recruitment, exacerbating experimental crescentic glomerulonephritis. Am J Pathol 2010; 177:2234-2244.
26. Wen Z, Xu L, Xu W, Yin Z, Gao X, Xiong S. Interleukin-17 expression positively correlates with disease severity of lupus nephritis by increasing anti-double-stranded DNA antibody production in a lupus model induced by activated lymphocyte derived DNA. PLOS ONE 2013; 8:e58161.
27. Summers SA, Phoon RK, Ooi JD, Holdsworth SR, Kitching AR. The IL-27 receptor has biphasic effects in crescentic glomerulonephritis mediated through Th1 responses. Am J Pathol 2011; 178:580-590.
28. Nacionales DC, Kelly KM, Lee PY etal. Type I interferon production by tertiary lymphoid tissue developing in response to 2, 6, 10, 14-tetramethyl-pentadecane (pristane). Am J Pathol 2006; 168:1227-1240.
29. Bosmann M, Sarma JV, Atefi G, Zetoune FS, Ward PA. Evidence for anti-inflammatory effects of C5a on the innate IL-17A/IL-23 axis. FASEB J 2012; 26:1640-1651.
30. Kasahara DI, Kim HY, Williams AS etal. Pulmonary inflammation induced by subacute ozone is augmented in adiponectin-deficient mice: role of IL-17A. J Immunol 2012; 188:4558-4567.
31. Li L, Huang L, Vergis AL etal. IL-17 produced by neutrophils regulates IFN-gamma-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury. J Clin Invest 2010; 120:331-342.
32. Paust HJ, Turner JE, Riedel JH etal. Chemokines play a critical role in the cross-regulation of Th1 and Th17 immune responses in murine crescentic glomerulonephritis. Kidney Int 2012; 82:72-83.
33. Crispin JC, Oukka M, Bayliss G etal. Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys. J Immunol 2008; 181:8761-8766.
34. Wong CK, Ho CY, Li EK, Lam CW. Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus. Lupus 2000; 9:589-593.
35. Yang J, Chu Y, Yang X etal. Th17 and natural Treg cell population dynamics in systemic lupus erythematosus. Arthritis Rheum 2009; 60:1472-1483.
36. Zhang Z, Kyttaris VC, Tsokos GC. The role of IL-23/IL-17 axis in lupus nephritis. J Immunol 2009; 183:3160-3169.
37. Kang HK, Liu M, Datta SK. Low-dose peptide tolerance therapy of lupus generates plasmacytoid dendritic cells that cause expansion of autoantigen-specific regulatory T cells and contraction of inflammatory Th17 cells. J Immunol 2007; 178:7849-7858.
38. Hsu HC, Yang P, Wang J etal. Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat Immunol 2008; 9:166-175.
39. Bai H, Cheng J, Gao X etal. IL-17/Th17 promotes type 1 T cell immunity against pulmonary intracellular bacterial infection through modulating dendritic cell function. J Immunol 2009; 183:5886-5895.
40. Gopal R, Lin Y, Obermajer N etal. IL-23-dependent IL-17 drives Th1-cell responses following Mycobacterium bovis BCG vaccination. Eur J Immunol 2012; 42:364-373.
41. Hou L, Jie Z, Desai M etal. Early IL-17 production by intrahepatic T cells is important for adaptive immune responses in viral hepatitis. J Immunol 2013; 190:621-629.
42. Ooi JD, Phoon RK, Holdsworth SR, Kitching AR. IL-23, not IL-12, directs autoimmunity to the Goodpasture antigen. J Am Soc Nephrol 2009; 20:980-989.
43. Urbonaviciute V, Starke C, Pirschel W etal. Toll-like receptor 2 is required for autoantibody production and development of renal disease in pristane-induced lupus. Arthritis Rheumat 2013; 65:1612-1623.
44. Chan RW, Lai FM, Li EK etal. Imbalance of Th1/Th2 transcription factors in patients with lupus nephritis. Rheumatology 2006; 45:951-957.
45. Calvani N, Richards HB, Tucci M, Pannarale G, Silvestris F. Up-regulation of IL-18 and predominance of a Th1 immune response is a hallmark of lupus nephritis. Clin Exp Immunol 2004; 138:171-178.